JP2019500385A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019500385A5 JP2019500385A5 JP2018534034A JP2018534034A JP2019500385A5 JP 2019500385 A5 JP2019500385 A5 JP 2019500385A5 JP 2018534034 A JP2018534034 A JP 2018534034A JP 2018534034 A JP2018534034 A JP 2018534034A JP 2019500385 A5 JP2019500385 A5 JP 2019500385A5
- Authority
- JP
- Japan
- Prior art keywords
- morpholine derivative
- tartrate
- powder
- ray diffraction
- diffraction pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 morpholine derivative malate Chemical class 0.000 claims description 45
- 238000000634 powder X-ray diffraction Methods 0.000 claims description 17
- 239000013078 crystal Substances 0.000 claims description 15
- 229940095064 tartrate Drugs 0.000 claims description 13
- 150000002780 morpholines Chemical class 0.000 claims description 12
- 229940049920 malate Drugs 0.000 claims description 7
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 6
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 150000004683 dihydrates Chemical class 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 2
- 229940116298 l- malic acid Drugs 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- YZMHQCWXYHARLS-UHFFFAOYSA-N naphthalene-1,2-disulfonic acid Chemical compound C1=CC=CC2=C(S(O)(=O)=O)C(S(=O)(=O)O)=CC=C21 YZMHQCWXYHARLS-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000113 differential scanning calorimetry Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 238000002411 thermogravimetry Methods 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 238000001757 thermogravimetry curve Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511016783.3 | 2015-12-29 | ||
| CN201511016783 | 2015-12-29 | ||
| PCT/CN2016/112966 WO2017114456A1 (zh) | 2015-12-29 | 2016-12-29 | 吗啉衍生物的盐及其晶型、其制备方法及药物组合物、用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019500385A JP2019500385A (ja) | 2019-01-10 |
| JP2019500385A5 true JP2019500385A5 (enExample) | 2019-09-12 |
| JP6818031B2 JP6818031B2 (ja) | 2021-01-20 |
Family
ID=59224612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018534034A Active JP6818031B2 (ja) | 2015-12-29 | 2016-12-29 | モルホリン誘導体の塩、結晶形、その製造方法、これらを含む医薬組成物およびその用途 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10519150B2 (enExample) |
| EP (1) | EP3398946B1 (enExample) |
| JP (1) | JP6818031B2 (enExample) |
| CN (3) | CN113816951B (enExample) |
| DK (1) | DK3398946T3 (enExample) |
| ES (1) | ES2918674T3 (enExample) |
| HU (1) | HUE059444T2 (enExample) |
| PL (1) | PL3398946T3 (enExample) |
| PT (1) | PT3398946T (enExample) |
| TW (1) | TWI705065B (enExample) |
| WO (1) | WO2017114456A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114129569A (zh) * | 2020-09-04 | 2022-03-04 | 上海医药集团股份有限公司 | 一种含氮的饱和杂环化合物的应用 |
| WO2022047730A1 (en) * | 2020-09-04 | 2022-03-10 | Shanghai Pharmaceuticals Holding Co., Ltd. | Methods to treat inflammatory bowel disease |
| CN116425677A (zh) * | 2022-01-11 | 2023-07-14 | 苏州恩华生物医药科技有限公司 | 氨基环丁烷衍生物的盐、其晶型及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK9742002A3 (en) * | 2000-01-07 | 2003-02-04 | Transform Pharmaceuticals Inc | High-throughput formation, identification, and analysis of diverse solid-forms |
| CN103562191B (zh) | 2011-03-16 | 2016-03-30 | 上海医药集团股份有限公司 | 含氮的饱和杂环化合物 |
| JP5764628B2 (ja) * | 2012-09-14 | 2015-08-19 | 田辺三菱製薬株式会社 | 医薬組成物 |
| ES2662026T3 (es) * | 2012-09-14 | 2018-04-05 | Mitsubishi Tanabe Pharma Corporation | Nuevo inhibidor de renina |
-
2016
- 2016-12-29 PL PL16881245.1T patent/PL3398946T3/pl unknown
- 2016-12-29 CN CN202110794158.0A patent/CN113816951B/zh active Active
- 2016-12-29 WO PCT/CN2016/112966 patent/WO2017114456A1/zh not_active Ceased
- 2016-12-29 EP EP16881245.1A patent/EP3398946B1/en active Active
- 2016-12-29 DK DK16881245.1T patent/DK3398946T3/da active
- 2016-12-29 PT PT168812451T patent/PT3398946T/pt unknown
- 2016-12-29 ES ES16881245T patent/ES2918674T3/es active Active
- 2016-12-29 TW TW105143910A patent/TWI705065B/zh active
- 2016-12-29 CN CN202110801274.0A patent/CN113816952A/zh active Pending
- 2016-12-29 US US16/066,490 patent/US10519150B2/en active Active
- 2016-12-29 CN CN201611246909.0A patent/CN106928218B/zh active Active
- 2016-12-29 HU HUE16881245A patent/HUE059444T2/hu unknown
- 2016-12-29 JP JP2018534034A patent/JP6818031B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5766687B2 (ja) | ７−［（３ｒ，４ｒ）−３−ヒドロキシ−４−ヒドロキシメチル−ピロリジン−１−イルメチル］−３，５−ジヒドロ−ピロロ［３，２−ｄ］ピリミジン−４−オンの有用な医薬塩 | |
| EP2970123B1 (en) | Salt of omecamtiv mecarbil and process for preparing salt | |
| AU2015330554B2 (en) | Crystal form of bisulfate of JAK inhibitor and preparation method therefor | |
| CN108290882B (zh) | 用于治疗呼吸道合胞病毒感染的4-喹唑啉胺衍生物的晶形 | |
| WO2018007927A1 (en) | Process for preparation of palbociclib | |
| JP7528060B2 (ja) | スルホンアミド構造キナーゼ阻害剤の新規塩酸塩形態 | |
| JP2019500385A5 (enExample) | ||
| JP6818031B2 (ja) | モルホリン誘導体の塩、結晶形、その製造方法、これらを含む医薬組成物およびその用途 | |
| TW202404604A (zh) | [(1S)-1-[(2S,4R,5R)-5-(5-胺基-2-酮基-噻唑并[4,5-d]嘧啶-3-基)-4-羥基-四氫呋喃-2-基]丙基]乙酸酯之新穎固態形式 | |
| CN102617332B (zh) | α-酮缬氨酸钙二水合物晶体及其制备方法 | |
| JP6577938B2 (ja) | セフジトレンピボキシルの新規結晶形態およびその製造方法 | |
| KR20200134928A (ko) | 발사르탄/사쿠비트릴 3소듐염 수화물의 결정형 및 그 제조방법 | |
| JP2025537478A (ja) | ジメチル－２，３－ジヒドロ－１ｈ－インデン誘導体の新規塩およびその製造方法 | |
| JP6663232B2 (ja) | 新規結晶構造を有するアジルサルタン及びその製造方法 | |
| KR20230062916A (ko) | 피마살탄 무수물 a형 결정다형 및 그 제조방법 | |
| KR20230062917A (ko) | 피마살탄 일수화물 b형 결정다형 및 그 제조방법 | |
| HK40050950B (zh) | 磺酰胺结构的激酶抑制剂的新盐酸盐形式 | |
| HK40050950A (en) | Novel hydrochloride salt forms of a sulfonamide structured kinase inhibitor | |
| KR20200068667A (ko) | 고체 형태의 스테모스피로닌 및 이의 염 | |
| WO2017035170A1 (en) | Solid state forms of cediranib maleate | |
| HK1258115B (en) | Crystalline forms of 4-quinazolinamine derivative for the treatment of respiratory syncytial virus infections | |
| TW201319042A (zh) | 硫酸卡維地洛的結晶、其製備方法及其在醫藥上的應用 | |
| HK1218544B (en) | Salt of omecamtiv mecarbil and process for preparing salt |